Pivekimab Sunirine Shows Promise in Relapsed/Refractory Acute Myeloid Leukemia Pivekimab Sunirine Shows Promise in Relapsed/Refractory Acute Myeloid Leukemia: A Look...
Leukemia
Gilead: CD47 Antibody Development Hit by Second Phase III Trials Termination Gilead: CD47 Antibody Development Hit by Second Phase III...
First release of base-edited CAR-T clinical data for children with T-ALL First release of base-edited CAR-T clinical data for...
1 patient died: Clinical trial of CD33-targeted CAR-T cell therapy was suspended 1 patient died: Clinical trial of CD33-targeted...
The clinical results of the first base-edited universal CAR-T therapy saved two children with leukemia The clinical results of...
Why can exposure to the sun much cause leukemia? Why can exposure to the sun much cause leukemia? ...
How does CAR-T cell therapy treat Acute Myeloid Leukemia (AML)? How does CAR-T cell therapy treat Acute Myeloid Leukemia...
NEJM: Why Leukemia is still diagnosed after gene therapy? NEJM: Why Leukemia is still diagnosed after gene therapy? Sickle...
